What Are the ASCCP Guidelines? | Cervical Cancer Screening Management . . . The ASCCP Guidelines provide evidence-based recommendations for cervical cancer screening, HPV testing, and management of abnormal results Explore current algorithms, clinical updates, and expert resources for women’s health professionals
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal . . . Updated US consensus guidelines for management of cervical screening abnormalities are needed to accommodate the 3 available cervical screening strategies: primary human papillomavirus (HPV) screening, cotesting with HPV testing and cervical cytology, and cervical cytology alone
Updated Guidelines for Management of Cervical Cancer Screening . . . The new consensus guidelines are an update of the 2012 ASCCP management guidelines and were developed with input from 19 stakeholder organizations, including ACOG, to provide recommendations for the care of patients with abnormal cervical cancer screening results
The Abnormal Pap: Updated ASCCP Management Guidelines • Allow updates to incorporate new test methods as they are validated, and to adjust for decreasing CIN3+ risks as more patients who received HPV vaccination reach screening age • Colposcopy practice must follow ASCCP guidelines with goal of finding CIN II or higher
ASCCP Guidelines: Colpo Pap Updates - tnafp. org Discuss special populations and considerations for screening outside the typical screening Apply management strategies for abnormal pap and HPV results by using the ASCCP application Understand the general principles and procedure of colposcopy
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal . . . Updated US consensus guidelines for management of cervical screening abnormalities are needed to accommodate the 3 available cervical screening strategies: primary human papillomavirus (HPV) screening, cotesting with HPV testing and cervical cytology, and cer-vical cytology alone
Table 2 – STI Treatment Guidelines § Negative HPV test or cotest (HPV plus Pap test) results only reduce risk sufficiently to defer colposcopy if performed for screening purposes within the last 5 years
ASCCP Enduring Consensus Guidelines for Cervical Cancer Screening The American Society of Colposcopy and Cervical Pathology (ASCCP), has published their enduring consensus guidelines and now recognizes the use of p16 Ki-67 dual-stain biomarkers (CINtec® PLUS Cytology) as an important technology to help clinicians triage patients and determine if their human papillomavirus (HPV) infection is transforming into
New and Updated Guidelines for Cervical Cancer Screening The management guidelines contained in the app have been updated to provide advice to clinicians regarding the management of clients with a positive HPV test and the reflex cytology that is performed in the same lab
ASCCP guidelines for BD Onclarity HPV Assays The American Society for Colposcopy and Cervical Pathology (ASCCP) has separated the BD OnclarityTM HPV Assay channels into three different risk-based tiers, which inform new clinical recommendations 2